QGel’s synthetic and tunable extracellular matrix (ECM) technology mimics the complex physiology of the human body, enabling the growth of any human or animal tissue in vitro. QGel enables drug development in a laboratory environment that accurately and reliably mimics the functioning of human organs, which means greater predictability of drug efficacy before the clinical phase. With an improved understanding of a drug’s potential, researchers spend more time and resources on the most promising therapies.